This review highlights the genetic link between RYR1 sequence variations and susceptibility to exertional rhabdomyolysis and stress-induced malignant hyperthermia.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to RYR1 variants in stress-induced MH; leaves open prospective validation before screening changes practice.
Exertional rhabdomyolysis (ER) and stress-induced malignant hyperthermia (MH) events are syndromes that primarily afflict military recruits in basic training and athletes. Events similar to those occurring in ER and in stress-induced MH events are triggered after exposure to anesthetic agents in MH-susceptible (MHS) patients. MH is an autosomal dominant hypermetabolic condition that occurs in genetically predisposed subjects during general anesthesia, induced by commonly used volatile anesthetics and/or the neuromuscular blocking agent succinylcholine. Triggering agents cause an altered intracellular calcium regulation. Mutations in RYR1 gene have been found in about 70% of MH families. The RYR1 gene encodes the skeletal muscle calcium release channel of the sarcoplasmic reticulum, commonly known as ryanodine receptor type 1 (RYR1). The present work reviews the documented cases of ER or of stress-induced MH events in which RYR1 sequence variations, associated or possibly associated to MHS status, have been identified.
No takes yet. Share an insight, caveat, or question.
Antonella Carsana (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: